Purchase Order 36C25925P0089

Award Date 10/18/24
Potential Completion Date 3/31/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dallas, TX 75201, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Merz Pharmaceuticals, LLC, a foreign-owned, for-profit pharmaceutical company, by the Veterans Integrated Service Network 12 (VISN 12). The contract is for the delivery of LEVODOPA 42MG INHL CAP 60, a pharmaceutical product, with a ceiling value of $143,560.80 and a period of performance through September 22, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business category. Merz Pharmaceuticals also holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,929.20, is for the delivery of NEMLUVIO 30 MG PENS, a medical product. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp is also the holder of a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $3,858.40 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of NEMLUVIO 30 MG PENS medical products, with a period of performance through June 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of NEMLUVIO 30 MG PENS. The contract has a ceiling value of $3,858.40 and a period of performance ending on June 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,892.90, is for the delivery of Nucala 100 mg/ml auto-injectors to support the medical supply needs of the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract is part of a larger indefinite delivery contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $13,776.05 award is for the supply of TREMFYA 100 MG/ML INJECTOR ML, a biologic medication, to fulfill the recurring pharmaceutical needs of military healthcare facilities. The award is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEMLUVIO 30 MG PENS, a medical product, with a ceiling value of $1,929.20 and a completion date of July 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of the pharmaceutical product TREMFYA 100 MG/ML INJECTORML, a fixed-price delivery order with a ceiling value of $22,908.90 and a performance period through March 21, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designation. The company is a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TREMFYA 100 MG/ML ONE-PRESS syringes, with a ceiling value of $16,604.80 and a period of performance through July 1, 2025. The award is not associated with a set-aside program and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $22,714.80 and is for the delivery of NUCALA 100 MG/ML AUTO-INJECTORML, a specialty pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's...

This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 19 to Galderma Laboratories, L.P., a foreign-owned, for-profit manufacturer of pharmaceutical products. The contract has a ceiling value of $18,377.86 and is for the delivery of 6 units of the injectable pharmaceutical product NEMOLIZUMAB CCP 30MG INJ. The contract has a period of performance from the award date of October 18, 2024 through March 31, 2025. There is no set-aside designation for this contract. Galderma Laboratories, L.P. is a significant supplier of specialized medical injectable medications to various VISNs within the Department of Veterans Affairs, as evidenced by their multiple recent contract awards for similar injectable pharmaceutical products.

Generated 3/14/25, 10:01 AM